Eli Lilly and Company (LLY) announced the successful completion of its acquisition of Morphic Holding (MORF). Morphic’s common stock will be delisted from The Nasdaq Global Market.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
- Biden administration announces lower prices for 10 Medicare drugs in 2026
- Roche passed on weight-loss pilll now being developed by Eli Lilly, FT says
- U.S. to announce prices for drugs in Medicare negotiations, NY Times says
- LLY, NVO: Which GLP-1 Stock Is the Better Bet?